Poly-<i>α</i>, <i>β</i>-<i><span style="font-variant: small-caps">d</span></i>, <i><span style="font-variant: small-caps">l</span></i>-Aspartyl-Arg-Gly-Asp-Ser-Based Urokinase Nanoparticles for Thrombolysis Therapy
The most concerning adverse effects of thrombolytic agents are major bleeding and intracranial hemorrhage due to their short half-life, low fibrin specificity, and high dosage. To alleviate bleeding side effects during thrombolytic therapy which would bring about the risk of aggravation, we try to f...
Glavni autori: | , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
MDPI AG
2023-03-01
|
Serija: | Molecules |
Teme: | |
Online pristup: | https://www.mdpi.com/1420-3049/28/6/2578 |